Apr 12, 2014 by Michael Douglass and Dave WilliamsonThe Hepatitis C Cure Poised to "Break the Country"Gilead's Sovaldi is selling well -- but will this pushback make a difference?
Apr 10, 2014 by Michael Douglass and Dave WilliamsonNew Painkiller Banned: Massachusetts FalloutGovernor Deval Patrick is the newest politician to go after Zohydro.
Apr 9, 2014 by Michael Douglass and Dave WilliamsonNext-Gen Breast Cancer Drugs Offer Patients HopeThese two drugs have investors excited about their potential.
Apr 6, 2014 by Michael Douglass and Dave WilliamsonObamacare at 7.1 Million: What You Need to KnowObamacare's newest numbers are in: Who's doing well?
Apr 6, 2014 by Michael Douglass and Dave WilliamsonAfter a 27% Plunge, Is Halozyme a Bad News Buy?Could the huge drop in Halozyme on Friday be a great opportunity for investors, or is this a company to avoid?
Apr 5, 2014 by Michael Douglass and Dave Williamson3 Stocks Furious At This Medicare ChangeThese three companies have got to be mad, as plans for an extensive change in Medicare are delayed.
Mar 30, 2014 by Michael Douglass and Dave Williamson2 Obamacare Prescription Drug Assistance Programs Ending: What You Need to KnowTwo major prescription drug makers have pulled out of their co-pay assistance programs. Are more to follow?
Mar 30, 2014 by Michael Douglass and Dave WilliamsonCongress Attempts to Fix Medicare: Winners and LosersDoctors decry: the fix is in.
Mar 28, 2014 by Michael Douglass and Dave WilliamsonObamacare's Newest Delay Is NeverendingObamacare exchange delays are announced. What you need to know.
Mar 23, 2014 by Michael Douglass and Dave WilliamsonObamacare and the Sequester: What You Need to KnowMore news out of Washington with eight days left in open enrollment.
Mar 23, 2014 by Michael Douglass and Dave WilliamsonBad News for Obamacare Insurers: Will Premiums Spike in 2015?Bad news for insurers in a new CMS draft letter. What's next?
Mar 23, 2014 by Michael Douglass and Dave Williamson28 AGs Attack: Who Will Blink First?These companies are coming under fire for selling tobacco products: What's next?
Mar 22, 2014 by Michael Douglass and Dave WilliamsonThis Generic Drug Threat Won't Go AwayA new FDA regulation has the Generic Pharmaceutical Association up in arms. What you need to know.
Mar 22, 2014 by Michael Douglass and Dave WilliamsonShould Doctors Fear This Little-Known Obamacare Change?Could this obscure rule make a big dent in hospital and physician profits?
Mar 16, 2014 by Michael Douglass and Dave WilliamsonHow to Profit from the Transformation of MedicareAccountable Care Organizations could fundamentally change how Medicare does business.
Mar 16, 2014 by Michael Douglass and Dave WilliamsonThe Best Stocks for Obamacare's Medicaid SurgeThese stocks have the most to gain from Obamacare's 4.4 million new Medicaid members.
Mar 15, 2014 by Michael Douglass and Dave WilliamsonWill Obamacare Harm These Biotech Stocks?The ACA doesn't just impact insurers and hospitals -- it may also directly affect biotech profitability.
Mar 15, 2014 by Michael Douglass and Dave WilliamsonObamacare Exchange Winners and Losers with 2 Weeks LeftHere's the state of play with 2 weeks until Obamacare enrollment ends.
Mar 14, 2014 by Michael Douglass and Dave Williamson3 Obamacare Terms to Know Before March 31st3 terms everyone should know when looking at health insurance through Obamacare.
Feb 17, 2014 by Michael Douglass and Max MacalusoMedicare, Medicaid, and Obamacare: What Investors Need to Know NowThese 3 areas have the potential to drive tremendous revenue and profitability changes for national insurers.
